CITIC Construction Investment: The performance valuation of the medical device sector continues to recover, focusing on high-growth companies in the third quarter

CITIC Construction Investment's research report indicates that after four consecutive years of adjustment, the medical device sector is experiencing an upturn this year. Most companies are showing a trend of performance growth that is lower in the first half and higher in the second half of the year, with the improvement in performance in the second half being more pronounced. In the short term, it is recommended to seize the performance valuation and repair opportunities of individual stocks that will see performance improvements in the third quarter of 2025 and 2026. It is expected that many companies will benefit from the release of new products and new business, achieving quarter-on-quarter improvements, or realizing high growth based on last year's low base. At the same time, it is suggested to pay attention to thematic investment opportunities in new technology directions such as brain-computer interfaces. In the long term, investment opportunities in the medical device industry come from innovation, going overseas, and mergers and acquisitions. The sector's innovation and internationalization capabilities are being recognized, and valuations are being reassessed